Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease.
Potkin SG, Anand R, Fleming K, Alva G, Keator D, Carreon D, Messina J, Wu JC, Hartman R, Fallon JH.
Potkin SG, et al.
Int J Neuropsychopharmacol. 2001 Sep;4(3):223-30. doi: 10.1017/S1461145701002528.
Int J Neuropsychopharmacol. 2001.
PMID: 11602028
Free article.
Clinical Trial.